{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:50:44Z","timestamp":1791654644268,"version":"4.3.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100018047","name":"NRG Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ijrobp.2025.08.021","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T21:29:36Z","timestamp":1755552576000},"page":"61-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Self-Perceived Hearing Outcomes With Radiation and Cisplatin or Radiation and Cetuximab for Patients With Human Papilloma Virus (HPV)-Positive Oropharyngeal Cancer\u2014Results From NRG Oncology RTOG 1016"],"prefix":"10.1016","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0330-5857","authenticated-orcid":false,"given":"Christina L.","family":"Runge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica A.","family":"Lyness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura L.","family":"Gillison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Adelstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Harari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolie","family":"Ringash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L.","family":"Geiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg A.","family":"Krempl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dukagjin M.","family":"Blakaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Edward","family":"Bates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Galloway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher U.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Gensheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal E.","family":"Dunlap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Phan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy J.","family":"Caudell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Daniel","family":"Pennington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro A.","family":"Torres-Saavedra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue S.","family":"Yom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quynh-Thu","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Movsas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2025.08.021_bib0001","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/00129492-200403000-00015","article-title":"A long-term study on hearing status in patients with nasopharyngeal carcinoma after radiotherapy","volume":"25","author":"Wang","year":"2004","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.ijrobp.2025.08.021_bib0002","doi-asserted-by":"crossref","DOI":"10.1007\/s00280-011-1656-2","article-title":"Prevention of cisplatin-induced hearing loss by administration of a thiosulfate-containing gel to the middle ear in a guinea pig model","volume":"68","author":"Berglin","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.ijrobp.2025.08.021_bib0003","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1470-2045(16)30625-8","article-title":"Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): A multicentre, randomised, controlled, open-label, phase III trial","volume":"18","author":"Freyer","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2025.08.021_bib0004","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.ijrobp.2022.09.003","article-title":"Radiotherapy with durvalumab vs. cetuximab in patients with locoregionally advanced head and neck cancer and a contraindication to cisplatin: Phase II results of NRG-HN004","volume":"114","author":"Mell","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.08.021_bib0005","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S1470-2045(22)00155-3","article-title":"Sodium thiosulfate for prevention of cisplatin-induced hearing loss: updated survival from ACCL0431","volume":"23","author":"Orgel","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2025.08.021_bib0006","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2025.08.021_bib0007","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(09)70311-0","article-title":"Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase III randomised trial, and relation between cetuximab-induced rash and survival","volume":"11","author":"Bonner","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2025.08.021_bib0008","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1200\/JCO.2015.62.5970","volume":"34","author":"Rosenthal","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.08.021_bib0009","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(18)32779-X","article-title":"Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology xxxxx): A randomised, multicentre, non-inferiority trial","volume":"393","author":"Gillison","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2025.08.021_bib0010","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/00003446-199012000-00004","article-title":"The hearing handicap inventory for adults: Psychometric adequacy and audiometric correlates","volume":"11","author":"Newman","year":"1990","journal-title":"Ear Hear"},{"key":"10.1016\/j.ijrobp.2025.08.021_bib0011","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00003446-199110000-00009","article-title":"Test-retest reliability of the hearing handicap inventory for adults","volume":"12","author":"Newman","year":"1991","journal-title":"Ear Hear"},{"key":"10.1016\/j.ijrobp.2025.08.021_bib0012","doi-asserted-by":"crossref","first-page":"S841","DOI":"10.1016\/j.annonc.2022.07.779","article-title":"655MO Quality of life in patients with p16+ oropharyngeal cancer receiving accelerated radiotherapy (RT) with either cisplatin or cetuximab in NRG\/RTOG 1016","volume":"33","author":"Ringash","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2025.08.021_bib0013","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/00003446-198205000-00006","article-title":"The hearing handicap inventory for the elderly: A new tool","volume":"3","author":"Ventry","year":"1982","journal-title":"Ear Hear"},{"key":"10.1016\/j.ijrobp.2025.08.021_bib0014","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1044\/jshr.2601.148","article-title":"Audiologic correlates of hearing handicap in the elderly","volume":"26","author":"Weinstein","year":"1983","journal-title":"J Speech Hear Res"},{"key":"10.1016\/j.ijrobp.2025.08.021_bib0015","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1044\/jshd.4804.379","article-title":"Audiometric correlates of the hearing handicap inventory for the elderly","volume":"48","author":"Weinstein","year":"1983","journal-title":"J Speech Hear Disord"},{"key":"10.1016\/j.ijrobp.2025.08.021_bib0016","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/00003446-198808000-00006","article-title":"Diagnostic performance of the hearing handicap inventory for the elderly (screening version) against differing definitions of hearing loss","volume":"9","author":"Lichtenstein","year":"1988","journal-title":"Ear Hear"},{"key":"10.1016\/j.ijrobp.2025.08.021_bib0017","first-page":"12","article-title":"The stigma attached to hearing impairment","volume":"43","author":"H\u00e9tu","year":"1996","journal-title":"Scand Audiol Suppl"},{"key":"10.1016\/j.ijrobp.2025.08.021_bib0018","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/AUD.0b013e3181a61f16","article-title":"Professionals with hearing loss: Maintaining that competitive edge","volume":"30","author":"Tye-Murray","year":"2009","journal-title":"Ear Hear"},{"key":"10.1016\/j.ijrobp.2025.08.021_bib0019","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1001\/jamaoto.2013.1713","article-title":"Statistical model for prediction of hearing loss in patients receiving cisplatin chemotherapy","volume":"139","author":"Johnson","year":"2013","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ijrobp.2025.08.021_bib0020","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.ijrobp.2007.01.042","article-title":"Risk factors of ototoxicity after cisplatin-based chemo-irradiation in patients with locally advanced head-and-neck cancer: A multivariate analysis","volume":"68","author":"Zuur","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.08.021_bib0021","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1159\/000095818","article-title":"Audiometric patterns in ototoxicity of intra-arterial cisplatin chemoradiation in patients with locally advanced head and neck cancer","volume":"11","author":"Zuur","year":"2006","journal-title":"Audiol Neurootol"},{"key":"10.1016\/j.ijrobp.2025.08.021_bib0022","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2025.08.021_bib0023","unstructured":"American Speech-Language-Hearing Association, Audiologic management of individuals receiving cochleotoxic drug therapy [guidelines]. 1994. Accessed January 20, 2024. https:\/\/www.asha.org\/policy."},{"key":"10.1016\/j.ijrobp.2025.08.021_bib0024","unstructured":"American Academy of Audiology. Position statement and clinical practice guidelines: Ototoxicity monitoring. 2009. Accessed January 20, 2024. https:\/\/www.audiology.org\/practice-guideline\/position-statement-and-practice-guidelines-on-ototoxicity-monitoring\/."},{"key":"10.1016\/j.ijrobp.2025.08.021_bib0025","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40463-021-00506-0","article-title":"Insight into the current practice of ototoxicity monitoring during cisplatin therapy","volume":"50","author":"Santucci","year":"2021","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ijrobp.2025.08.021_bib0026","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.oraloncology.2018.12.010","article-title":"Predictors of cisplatin-induced ototoxicity and survival in chemoradiation treated head and neck cancer patients","volume":"89","author":"Teft","year":"2019","journal-title":"Oral Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301625061577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301625061577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:47:35Z","timestamp":1791654455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301625061577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0360301625061577"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.08.021","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Self-Perceived Hearing Outcomes With Radiation and Cisplatin or Radiation and Cetuximab for Patients With Human Papilloma Virus (HPV)-Positive Oropharyngeal Cancer\u2014Results From NRG Oncology RTOG 1016","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.08.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}